Dr. Diana Brixner has been awarded a 2021 Research Award in Value Assessment from Pharmaceutical Research and Manufacturers of America (PhRMA). The award provides $100,000 to fund her research project titled “Understanding Patient Cost Sharing Thresholds for High and Low Value Care Towards Development of a Value-Based Formulary.”
The purpose of the study is to estimate patient preferences and willingness-to-pay for high and low-value medications and inform VBF design. The findings of this study will provide real-world patient preferences that will inform the U of U Health Plans VBF currently in development and supportive education for all stakeholders. By aligning patient and stakeholder preferences, the study has the potential to yield improved patients outcomes and increase cost-savings to patients, beneficiaries, and health plans.
